Generation of induced pluripotent stem cell-like lines from human pancreatic ductal adenocarcinoma

Jungsun Kim, Kenneth S. Zaret

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, mainly because the tumors are detected too late for effective treatment or for developing suitable therapeutics. Reprogramming cancer cells to pluripotency by induced pluripotent stem cell (iPSC) technology, which can be then programmed back to their original cellular state, allows for studying the dynamic events in the course of the disease progression. Thus, we applied iPSC technology to model early progression of PDAC. We showed that when an iPS-like cell line, designated 10-22, derived from human recurrent PDAC, was injected into immunodeficient mice, the cells consistently recapitulated preinvasive, pancreatic intraepithelial neoplasia (PanIN) to invasive stages of human PDAC. This model was recently validated by revealing a new biomarker that can classify early resectable PDAC patients from healthy subjects. The procedure to derive iPSCs from human PDAC is principally the same as the procedure to generate iPSCs from normal human fibroblast. However, the heterogeneous initial populations, different cellular states, and active memory of pancreatic epithelial cells challenge for making iPSC-like lines from human PDAC. Herein, we describe how to create and maintain iPSC-like line from human PDAC by lentiviral transduction of reprogramming factors.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages33-53
Number of pages21
DOIs
StatePublished - Jan 1 2019

Publication series

NameMethods in Molecular Biology
Volume1882
ISSN (Print)1064-3745

Fingerprint

Induced Pluripotent Stem Cells
Adenocarcinoma
Cell Line
Technology
Neoplasms
Disease Progression
Healthy Volunteers
Fibroblasts
Biomarkers
Epithelial Cells
Therapeutics

Keywords

  • Induced pluripotent stem cell
  • Pancreatic ductal adenocarcinoma
  • Pancreatic intraepithelial neoplasia

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Kim, J., & Zaret, K. S. (2019). Generation of induced pluripotent stem cell-like lines from human pancreatic ductal adenocarcinoma. In Methods in Molecular Biology (pp. 33-53). (Methods in Molecular Biology; Vol. 1882). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-8879-2_4

Generation of induced pluripotent stem cell-like lines from human pancreatic ductal adenocarcinoma. / Kim, Jungsun; Zaret, Kenneth S.

Methods in Molecular Biology. Humana Press Inc., 2019. p. 33-53 (Methods in Molecular Biology; Vol. 1882).

Research output: Chapter in Book/Report/Conference proceedingChapter

Kim, J & Zaret, KS 2019, Generation of induced pluripotent stem cell-like lines from human pancreatic ductal adenocarcinoma. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1882, Humana Press Inc., pp. 33-53. https://doi.org/10.1007/978-1-4939-8879-2_4
Kim J, Zaret KS. Generation of induced pluripotent stem cell-like lines from human pancreatic ductal adenocarcinoma. In Methods in Molecular Biology. Humana Press Inc. 2019. p. 33-53. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-8879-2_4
Kim, Jungsun ; Zaret, Kenneth S. / Generation of induced pluripotent stem cell-like lines from human pancreatic ductal adenocarcinoma. Methods in Molecular Biology. Humana Press Inc., 2019. pp. 33-53 (Methods in Molecular Biology).
@inbook{8a4536b1d07d4db180cb405ec423f697,
title = "Generation of induced pluripotent stem cell-like lines from human pancreatic ductal adenocarcinoma",
abstract = "Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, mainly because the tumors are detected too late for effective treatment or for developing suitable therapeutics. Reprogramming cancer cells to pluripotency by induced pluripotent stem cell (iPSC) technology, which can be then programmed back to their original cellular state, allows for studying the dynamic events in the course of the disease progression. Thus, we applied iPSC technology to model early progression of PDAC. We showed that when an iPS-like cell line, designated 10-22, derived from human recurrent PDAC, was injected into immunodeficient mice, the cells consistently recapitulated preinvasive, pancreatic intraepithelial neoplasia (PanIN) to invasive stages of human PDAC. This model was recently validated by revealing a new biomarker that can classify early resectable PDAC patients from healthy subjects. The procedure to derive iPSCs from human PDAC is principally the same as the procedure to generate iPSCs from normal human fibroblast. However, the heterogeneous initial populations, different cellular states, and active memory of pancreatic epithelial cells challenge for making iPSC-like lines from human PDAC. Herein, we describe how to create and maintain iPSC-like line from human PDAC by lentiviral transduction of reprogramming factors.",
keywords = "Induced pluripotent stem cell, Pancreatic ductal adenocarcinoma, Pancreatic intraepithelial neoplasia",
author = "Jungsun Kim and Zaret, {Kenneth S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-8879-2_4",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "33--53",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Generation of induced pluripotent stem cell-like lines from human pancreatic ductal adenocarcinoma

AU - Kim, Jungsun

AU - Zaret, Kenneth S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, mainly because the tumors are detected too late for effective treatment or for developing suitable therapeutics. Reprogramming cancer cells to pluripotency by induced pluripotent stem cell (iPSC) technology, which can be then programmed back to their original cellular state, allows for studying the dynamic events in the course of the disease progression. Thus, we applied iPSC technology to model early progression of PDAC. We showed that when an iPS-like cell line, designated 10-22, derived from human recurrent PDAC, was injected into immunodeficient mice, the cells consistently recapitulated preinvasive, pancreatic intraepithelial neoplasia (PanIN) to invasive stages of human PDAC. This model was recently validated by revealing a new biomarker that can classify early resectable PDAC patients from healthy subjects. The procedure to derive iPSCs from human PDAC is principally the same as the procedure to generate iPSCs from normal human fibroblast. However, the heterogeneous initial populations, different cellular states, and active memory of pancreatic epithelial cells challenge for making iPSC-like lines from human PDAC. Herein, we describe how to create and maintain iPSC-like line from human PDAC by lentiviral transduction of reprogramming factors.

AB - Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, mainly because the tumors are detected too late for effective treatment or for developing suitable therapeutics. Reprogramming cancer cells to pluripotency by induced pluripotent stem cell (iPSC) technology, which can be then programmed back to their original cellular state, allows for studying the dynamic events in the course of the disease progression. Thus, we applied iPSC technology to model early progression of PDAC. We showed that when an iPS-like cell line, designated 10-22, derived from human recurrent PDAC, was injected into immunodeficient mice, the cells consistently recapitulated preinvasive, pancreatic intraepithelial neoplasia (PanIN) to invasive stages of human PDAC. This model was recently validated by revealing a new biomarker that can classify early resectable PDAC patients from healthy subjects. The procedure to derive iPSCs from human PDAC is principally the same as the procedure to generate iPSCs from normal human fibroblast. However, the heterogeneous initial populations, different cellular states, and active memory of pancreatic epithelial cells challenge for making iPSC-like lines from human PDAC. Herein, we describe how to create and maintain iPSC-like line from human PDAC by lentiviral transduction of reprogramming factors.

KW - Induced pluripotent stem cell

KW - Pancreatic ductal adenocarcinoma

KW - Pancreatic intraepithelial neoplasia

UR - http://www.scopus.com/inward/record.url?scp=85055659556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055659556&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-8879-2_4

DO - 10.1007/978-1-4939-8879-2_4

M3 - Chapter

T3 - Methods in Molecular Biology

SP - 33

EP - 53

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -